UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 542

Sortiert nach

Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds Enthesitis Index (LEI), Spondyloarthritis Research Consortium of Canada (SPARCC), Maastricht Ankylosing Spondylitis Enthesis Score (MASES), Leeds Dactylitis Index (LDI), Patient Global for Psoriatic Arthritis, Dermatology Life Quality Index (DLQI), Psor

Arthritis care & research (2010), 2011-11, Vol.63 (S11), p.S64-S85

Mease, Philip J.

2011

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis

Current opinion in rheumatology, 2015-03, Vol.27 (2), p.127-133

Mease, Philip J

2015

Link zum Volltext

Verfügbarkeit prüfen

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria

Seminars in arthritis and rheumatism, 2016-12, Vol.46 (3), p.319-329

2016

Link zum Volltext

Verfügbarkeit prüfen

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

Arthritis & rheumatology (Hoboken, N.J.), 2019-07, Vol.71 (7), p.1112-1124

2019

Link zum Volltext

Verfügbarkeit prüfen

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2015-09, Vol.386 (9999), p.1137-1146

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Arthritis research & therapy, 2018-03, Vol.20 (1), p.47-11, Article 47

2018

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

American journal of human genetics, 2015-12, Vol.97 (6), p.816-836

2015

Link zum Volltext

Verfügbarkeit prüfen

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

Journal of rheumatology, 2018-10, Vol.45 (10), p.1389

2018

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Journal of the American Academy of Dermatology, 2013-11, Vol.69 (5), p.729-735

2013

Link zum Volltext

Verfügbarkeit prüfen

Biologic Therapy for Psoriatic Arthritis

Rheumatic diseases clinics of North America, 2015-11, Vol.41 (4), p.723

Mease, Philip J

2015

Link zum Volltext

Verfügbarkeit prüfen

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis

Arthritis research & therapy, 2019-05, Vol.21 (1), p.118-118, Article 118

2019

Link zum Volltext

Verfügbarkeit prüfen

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research

Arthritis research & therapy, 2020-02, Vol.22 (1), p.18-18, Article 18

2020

Link zum Volltext

Verfügbarkeit prüfen

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

Annals of the rheumatic diseases, 2020-01, Vol.79 (1), p.88

2020

Link zum Volltext

Verfügbarkeit prüfen

B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application

Journal of rheumatology, 2008-07, Vol.35 (7), p.1245

Mease, Philip J

2008

Link zum Volltext

Verfügbarkeit prüfen

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

Arthritis research & therapy, 2021-09, Vol.23 (1), p.1-236, Article 236

2021

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

Arthritis research & therapy, 2023-08, Vol.25 (1), p.1-153, Article 153

2023

Link zum Volltext

Verfügbarkeit prüfen

Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment

Current opinion in rheumatology, 2017-07, Vol.29 (4), p.304-310

Mease, Philip J

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

Acta dermato-venereologica, 2022-04, Vol.102, p.adv00698-adv00698

2022

Link zum Volltext

Verfügbarkeit prüfen

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

Journal of rheumatology, 2009-02, Vol.36 (2), p.398

2009

Link zum Volltext

Verfügbarkeit prüfen

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis

Arthritis research & therapy, 2021-07, Vol.23 (1), p.190-190, Article 190

2021

Link zum Volltext

Verfügbarkeit prüfen

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia

Journal of rheumatology, 2008-03, Vol.35 (3), p.502

2008

Link zum Volltext

Verfügbarkeit prüfen

Further Strategies for Treating Fibromyalgia: The Role of Serotonin and Norepinephrine Reuptake Inhibitors

The American journal of medicine, 2009-12, Vol.122 (12), p.S44-S55

Mease, Philip J., MD

2009

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of psoriatic arthritis in the population of the United States

Journal of the American Academy of Dermatology, 2005-10, Vol.53 (4), p.573.e1-573.e13

2005

Link zum Volltext

Verfügbarkeit prüfen

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Rheumatic & musculoskeletal diseases open, 2023-02, Vol.9 (1), p.e002735

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 542

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(500)
Mit Volltextzugriff
(356)

Publikationsform

Artikel
(525)
Buchkapitel
(14)
Bücher
(3)

Sprache

Englisch
(542)
Japanisch
(40)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(390)
Science & Technology
(390)
Rheumatology
(362)
Humans
(358)
Psoriatic Arthritis
(259)
Psoriasis
(158)
Female
(154)
Male
(147)
Treatment Outcome
(145)
Arthritis, Psoriatic - Drug Therapy
(135)
Middle Aged
(132)
Adult
(128)
Biological And Medical Sciences
(113)
Medical Sciences
(113)
Severity Of Illness Index
(107)
Diseases Of The Osteoarticular System
(100)
Patients
(97)
Antirheumatic Agents - Therapeutic Use
(96)
Dermatology
(93)
Arthritis, Psoriatic - Diagnosis
(91)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis

2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria

Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

Efficacy and safety of secukinumab administration by autoinjector in patients with psoriatic arthritis: results from a randomized, placebo-controlled trial (FUTURE 3)

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry

Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics

Biologic Therapy for Psoriatic Arthritis

Long-term experience with apremilast in patients with psoriatic arthritis: 5-year results from a PALACE 1-3 pooled analysis

Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

B cell-targeted therapy in autoimmune disease: rationale, mechanisms, and clinical application

Treatment patterns in rheumatoid arthritis patients newly initiated on biologic and conventional synthetic disease-modifying antirheumatic drug therapy and enrolled in a North American clinical registry

Efficacy of tofacitinib on enthesitis in patients with active psoriatic arthritis: analysis of pooled data from two phase 3 studies

Fibromyalgia, a missed comorbidity in spondyloarthritis: prevalence and impact on assessment and treatment

Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data

The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia

Further Strategies for Treating Fibromyalgia: The Role of Serotonin and Norepinephrine Reuptake Inhibitors

Epidemiology of psoriatic arthritis in the population of the United States

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Suchergebnisse filtern